Status:
COMPLETED
Omarigliptin & Trelagliptin in Twelve Healthy Egyptian Volunteers
Lead Sponsor:
British University In Egypt
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
MALE
23-37 years
Phase:
NA
Brief Summary
The proposed study will consider the LC-MS/MS quantitative determination of Omarigliptin \& Trelagliptin after administration to twelve Egyptian volunteers. The main aim of the study is to confirm tha...
Eligibility Criteria
Inclusion
- Healthy volunteers
- Must be able to swallow tablets
Exclusion
- Insulin dependent diabetes
- Type-2 diabetes
- Hospitalized within 1 week
Key Trial Info
Start Date :
November 20 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 28 2017
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT03362398
Start Date
November 20 2017
End Date
November 28 2017
Last Update
December 5 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The British University in Egypt
Cairo, Egypt